These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 25188528

  • 21. Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic rats.
    Czirok S, Fang L, Radovits T, Szabó G, Szénási G, Rosivall L, Merkely B, Kökény G.
    Sci Rep; 2017 Sep 11; 7(1):11218. PubMed ID: 28894114
    [Abstract] [Full Text] [Related]

  • 22. Omentin-1 exerts bone-sparing effect in ovariectomized mice.
    Xie H, Xie PL, Luo XH, Wu XP, Zhou HD, Tang SY, Liao EY.
    Osteoporos Int; 2012 Apr 11; 23(4):1425-36. PubMed ID: 21755404
    [Abstract] [Full Text] [Related]

  • 23. Fast and long acting neoflavonoids dalbergin isolated from Dalbergia sissoo heartwood is osteoprotective in ovariectomized model of osteoporosis: Osteoprotective effect of Dalbergin.
    Choudhary D, Kushwaha P, Gautam J, Kumar P, Verma A, Kumar A, Maurya SW, Siddiqui IR, Mishra PR, Maurya R, Trivedi R.
    Biomed Pharmacother; 2016 Oct 11; 83():942-957. PubMed ID: 27522257
    [Abstract] [Full Text] [Related]

  • 24. Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.
    Wang WZ, Jones AW, Wang M, Durante W, Korthuis RJ.
    Am J Physiol Heart Circ Physiol; 2013 Aug 15; 305(4):H521-32. PubMed ID: 23771693
    [Abstract] [Full Text] [Related]

  • 25. Nitric oxide stimulates human sperm motility via activation of the cyclic GMP/protein kinase G signaling pathway.
    Miraglia E, De Angelis F, Gazzano E, Hassanpour H, Bertagna A, Aldieri E, Revelli A, Ghigo D.
    Reproduction; 2011 Jan 15; 141(1):47-54. PubMed ID: 20965947
    [Abstract] [Full Text] [Related]

  • 26. Chlorogenic Acid Prevents Osteoporosis by Shp2/PI3K/Akt Pathway in Ovariectomized Rats.
    Zhou RP, Lin SJ, Wan WB, Zuo HL, Yao FF, Ruan HB, Xu J, Song W, Zhou YC, Wen SY, Dai JH, Zhu ML, Luo J.
    PLoS One; 2016 Jan 15; 11(12):e0166751. PubMed ID: 28033335
    [Abstract] [Full Text] [Related]

  • 27. Anti-osteoporosis activity of Sanguinarine in preosteoblast MC3T3-E1 cells and an ovariectomized rat model.
    Zhang F, Xie J, Wang G, Zhang G, Yang H.
    J Cell Physiol; 2018 Jun 15; 233(6):4626-4633. PubMed ID: 28926099
    [Abstract] [Full Text] [Related]

  • 28. The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems.
    Vandendriessche B, Rogge E, Goossens V, Vandenabeele P, Stasch JP, Brouckaert P, Cauwels A.
    PLoS One; 2013 Jun 15; 8(8):e72155. PubMed ID: 24015214
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers.
    Frey R, Mück W, Unger S, Artmeier-Brandt U, Weimann G, Wensing G.
    J Clin Pharmacol; 2008 Dec 15; 48(12):1400-10. PubMed ID: 18779378
    [Abstract] [Full Text] [Related]

  • 30. Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator, Riociguat, and an Activator, Cinaciguat, During NO-Modulation in Healthy Pigs.
    Næsheim T, How OJ, Myrmel T.
    J Cardiovasc Pharmacol Ther; 2021 Jan 15; 26(1):75-87. PubMed ID: 32662299
    [Abstract] [Full Text] [Related]

  • 31. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C, Kern J, Heitz M, Plas E, Zwerschke W, Mattesich M, Sandner P, Berger P.
    Exp Cell Res; 2015 Nov 01; 338(2):162-9. PubMed ID: 26410556
    [Abstract] [Full Text] [Related]

  • 32. The Potential of sGC Modulators for the Treatment of Age-Related Fibrosis: A Mini-Review.
    Sandner P, Berger P, Zenzmaier C.
    Gerontology; 2017 Nov 01; 63(3):216-227. PubMed ID: 27784018
    [Abstract] [Full Text] [Related]

  • 33. Nitric oxide and cyclic GMP functions in bone.
    Kalyanaraman H, Schall N, Pilz RB.
    Nitric Oxide; 2018 Jun 01; 76():62-70. PubMed ID: 29550520
    [Abstract] [Full Text] [Related]

  • 34. Osteogenic effect of an adiponectin-derived short peptide that rebalances bone remodeling: a potential disease-modifying approach for postmenopausal osteoporosis therapy.
    Rajput S, Kulkarni C, Sharma S, Tomar MS, Khatoon S, Gupta A, Sanyal S, Shrivastava A, Ghosh JK, Chattopadhyay N.
    Arch Pharm Res; 2024 Sep 01; 47(8-9):736-755. PubMed ID: 39073743
    [Abstract] [Full Text] [Related]

  • 35. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
    Kassem M.
    APMIS Suppl; 1997 Sep 01; 71():1-30. PubMed ID: 9357492
    [Abstract] [Full Text] [Related]

  • 36. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
    Yang YT, Meng JH, Hu B, Ma CY, Zhao CC, Teng WS, Hong JQ, Li SH, Jiang GY, Wang C, Zhou CH, Yan SG.
    Life Sci; 2018 Sep 15; 209():409-419. PubMed ID: 30096387
    [Abstract] [Full Text] [Related]

  • 37. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
    Korkmaz S, Loganathan S, Mikles B, Radovits T, Barnucz E, Hirschberg K, Li S, Hegedüs P, Páli S, Weymann A, Karck M, Szabó G.
    J Cardiovasc Pharmacol Ther; 2013 Jan 15; 18(1):70-7. PubMed ID: 22914857
    [Abstract] [Full Text] [Related]

  • 38. Effect of nitric oxide on mouse clonal osteogenic cell, MC3T3-E1, proliferation in vitro.
    Kanamaru Y, Takada T, Saura R, Mizuno K.
    Kobe J Med Sci; 2001 Feb 15; 47(1):1-11. PubMed ID: 11565190
    [Abstract] [Full Text] [Related]

  • 39. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
    Iwaniec UT, Yuan D, Power RA, Wronski TJ.
    J Bone Miner Res; 2006 Jul 15; 21(7):1068-74. PubMed ID: 16813527
    [Abstract] [Full Text] [Related]

  • 40. Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats.
    Comeglio P, Cellai I, Filippi S, Corno C, Corcetto F, Morelli A, Maneschi E, Maseroli E, Mannucci E, Fambrini M, Maggi M, Vignozzi L.
    J Sex Med; 2016 Dec 15; 13(12):1858-1871. PubMed ID: 27914563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.